Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe Record History now shows a new page revision: v3.6.4, added to the history. The previous revision entry, v3.6.3, was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, replacing the prior v3.6.2. This reflects a software update to the page's history interface rather than changes to trial information.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history, and the earlier entry (v3.6.0) was removed, indicating a minor backend update to the page history.SummaryDifference0.1%

- Check54 days agoChange DetectedRecruitment status updated to no longer look for participants. The study record was revised to version 3.6.0, replacing the previous 3.5.5 version.SummaryDifference0.3%

- Check61 days agoChange DetectedA new version entry (v3.5.5) was added on 2026-06-04, introducing updated Study Status and Contacts/Locations sections; the previous revision (v3.5.4) was removed on 2026-04-14.SummaryDifference0.4%

- Check83 days agoChange DetectedA new revision label v3.5.4 appears in the record history, replacing the previous v3.5.3. This reflects an internal update to the page rendering rather than any change to trial data or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.